Cargando…
Patients as research partners in preference studies: learnings from IMI-PREFER
BACKGROUND: There is growing recognition of the importance of patient and public stakeholder involvement (PPI) in patient preference research. However, limited evidence exists regarding the impact, barriers and enablers of PPI in preference studies. The Innovative Medicines Initiative (IMI)-PREFER p...
Autores principales: | Smith, Meredith Y., Janssens, Rosanne, Jimenez-Moreno, A. Cecilia, Cleemput, Irina, Muller, Mireille, Oliveri, Serena, Simons, Gwenda, Strammiello, Valentina, Huys, Isabelle, Falahee, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080166/ https://www.ncbi.nlm.nih.gov/pubmed/37029449 http://dx.doi.org/10.1186/s40900-023-00430-9 |
Ejemplares similares
-
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action
por: Janssens, Rosanne, et al.
Publicado: (2023) -
A study protocol for quantifying patient preferences in neuromuscular disorders: a case study of the IMI PREFER Project
por: Jimenez-Moreno, Aura Cecilia, et al.
Publicado: (2020) -
Opportunities and Challenges of Web-Based and Remotely Administered Surveys for Patient Preference Studies in a Vulnerable Population
por: Oliveri, Serena, et al.
Publicado: (2021) -
Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review
por: Janssens, Rosanne, et al.
Publicado: (2019) -
What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences
por: Petrocchi, Serena, et al.
Publicado: (2021)